Last reviewed · How we verify
Analgesic Agent
An analgesic agent that reduces pain through modulation of pain signaling pathways.
An analgesic agent that reduces pain through modulation of pain signaling pathways. Used for Cancer-related pain (phase 3 development).
At a glance
| Generic name | Analgesic Agent |
|---|---|
| Sponsor | Alliance for Clinical Trials in Oncology |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
The specific mechanism is not detailed in the provided information. As a general analgesic in phase 3 development by the Alliance for Clinical Trials in Oncology, it likely targets pain management in cancer patients, potentially through neuropathic pain reduction, inflammatory pathway inhibition, or opioid receptor modulation. Further characterization would require additional clinical trial data.
Approved indications
- Cancer-related pain (phase 3 development)
Common side effects
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS) (NA)
- Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery (NA)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Analgesic Agent CI brief — competitive landscape report
- Analgesic Agent updates RSS · CI watch RSS
- Alliance for Clinical Trials in Oncology portfolio CI